Comron Hassanzadeh
Overview
Explore the profile of Comron Hassanzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
262
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassanzadeh C, Mohamad O, Bruno T, Wang L, Kudchakar R, Bathala T, et al.
Brachytherapy
. 2025 Jan;
24(2):231-237.
PMID: 39755443
Background: To determine outcomes of MRI-assisted radiosurgery (MARS) for salvage brachytherapy using the radioisotope Pd after various upfront treatments including surgery, external beam radiotherapy, and brachytherapy. Methods: We retrospectively reviewed...
2.
Zhao Y, Cozma A, Ding Y, Perles L, Reiazi R, Chen X, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682173
Advancements in radiotherapy technology now enable the delivery of ablative doses to targets in the upper urinary tract, including primary renal cell carcinoma (RCC) or upper tract urothelial carcinomas (UTUC),...
3.
Carriere P, Alhalabi O, Gao J, Mohamad O, Campbell M, Shah A, et al.
Clin Transl Radiat Oncol
. 2024 Oct;
49:100866.
PMID: 39403573
Purpose: Trimodality therapy for muscle-invasive bladder cancer (MIBC) yields similar oncologic outcomes compared to radical cystectomy in appropriately selected patients; however, data regarding locally advanced MIBC (LA-MIBC) is limited. We...
4.
Thomas H, Chen J, Shaheen H, Sabbagh A, Abdul-Baki H, Chau O, et al.
J Contemp Brachytherapy
. 2024 Apr;
16(1):1-5.
PMID: 38584887
Introduction: Inflammatory bowel disease (IBD) is a relative contraindication to external beam radiation therapy (EBRT) for prostate cancer patients due to fear of increased risk of gastrointestinal (GI) toxicity. High-dose-rate...
5.
Thomas H, Chen J, Abdul-Baki H, Sabbagh A, Shaheen H, Chau O, et al.
Brachytherapy
. 2023 Dec;
23(2):173-178.
PMID: 38160102
Purpose: A history of prior pelvic radiation therapy (RT) for rectal cancer is a relative contraindication for definitive RT for prostate cancer. High-dose-rate (HDR) brachytherapy can significantly limit the dose...
6.
Hassanzadeh C, Mirza K, Kalaghchi B, Fallahian F, Chin R, Roy A, et al.
Dis Colon Rectum
. 2023 Oct;
67(1):54-61.
PMID: 37787502
Background: Management of lateral pelvic lymph nodes in locally advanced rectal cancer is controversial, with limited data indicating the optimal approach. In addition, no data exist regarding the treatment of...
7.
Hassanzadeh C, Rudra S, Bommireddy A, Hawkins W, Wang-Gillam A, Fields R, et al.
Adv Radiat Oncol
. 2021 Mar;
6(1):100506.
PMID: 33665480
Purpose: Patients with inoperable pancreatic adenocarcinoma have limited options, with traditional chemoradiation providing modest clinical benefit and an otherwise poor prognosis. Stereotactic body radiation therapy for pancreatic cancer is limited...
8.
Hassanzadeh C, Rudra S, Ma S, Brenneman R, Huang Y, Henke L, et al.
Radiother Oncol
. 2021 Feb;
158:237-243.
PMID: 33587967
Background And Purpose: Consensus for defining gross tumor volume (GTV) and clinical target volume (CTV) for limited-field radiation therapy (LFRT) of GBM are not well established. We leveraged a department...
9.
Hassanzadeh C, Sita T, Savoor R, Samson P, Bradley J, Gentile M, et al.
J Thorac Dis
. 2020 Dec;
12(11):6690-6700.
PMID: 33282370
Background: Consolidation durvalumab improved overall survival (OS) in locally advanced non-small cell lung cancer (LA-NSCLC) treated with chemoradiotherapy (CRT) in the PACIFIC trial; however, pneumonitis was increased with durvalumab. We...
10.
Hassanzadeh C, Roach M, Rich K, Karraker P, Robinson C, Michalski J, et al.
Pract Radiat Oncol
. 2020 Feb;
10(4):e250-e254.
PMID: 32004704
Purpose: The medical necessity of stereotactic radiosurgery (SRS) is nonuniform across insurance policies. The American Society for Radiation Oncology (ASTRO) created a model policy based on the consensus of the...